ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "anti-CCP antibodies"

  • Abstract Number: 529 • 2015 ACR/ARHP Annual Meeting

    Immunoglobulin-a and Immunoglobulin-G Isotypes of Anti-CCP Antibodies Are Present in the Sputum of Subjects at Risk for Future Development of RA

    Kristen Demoruelle1, Linh Ho2, Michael H. Weisman3, Ryan W. Gan4, Mark C. Parish1, Marie L. Feser1, Chelsie Fleischer1, Michael Mahler5, Andrea Seaman5, Jill M. Norris4, V. Michael Holers1 and Kevin D. Deane1, 1Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 2University of Colorado School of Medicine, Aurora, CO, 3Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 4Epidemiology, Colorado School of Public Health, Aurora, CO, 5Inova Diagnostics, San Diego, CA

    Background/Purpose: Serum elevations of anti-CCP prior to inflammatory arthritis (IA) in RA suggest that anti-CCP is generated at a site outside of the joints. Data…
  • Abstract Number: 2616 • 2015 ACR/ARHP Annual Meeting

    Study of Anti-Carbamylated Protein Antibody in the Rheumatoid Patients Who Were Clinically Active and Under Treatment with Biological Dmards

    Kazuko Shiozawa1 and Shunichi Shiozawa2, 1Rheumatic Diseases Center, Konan Kakogawa Hospital, Kakogawa, Japan, 2Department of Medicine, Rheumatic Diseases Unit, Kyushu University Beppu Hospital, Beppu, Japan

    Background/Purpose: A newly discovered anti-carbamylated protein antibody (anti-CarP) is found prior to disease-onset, associates with the conversion towards arthralgia and with a more severe disease…
  • Abstract Number: 530 • 2015 ACR/ARHP Annual Meeting

    Immunomodulation of Naïve RA Patients PBMCs with a Multi-Epitope Peptide Derived from Citrullinated Autoantigens

    Smadar Gertel1, Yehuda Shoenfeld2 and Howard Amital3, 1Sheba Medical Center, Zabludowicz Center for Autoimmune Diseases, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel, 2Head Dept of Medicine B, Sheba Medical Center, Ramat-Gan, Israel, 3Sheba Medical Center, Tel-Hashomer, Israel

    Background/Purpose: Citrullinated peptides are major targets of disease-specific autoantibodies in rheumatoid arthritis (RA). We generated a multi-epitope citrullinated peptide (Cit-ME), derived from major prevalent citrullinated…
  • Abstract Number: 2660 • 2015 ACR/ARHP Annual Meeting

    Elevated 14-3-3η Serum Protein Levels Increase RA Confirmation Rates in Recent-Onset Polyarthritis Patients

    Nathalie Carrier1, Anthony Marotta2, Artur de Brum-Fernandes3,4, Patrick Liang3,4, Ariel Masetto5,6, Yuan Gui2, Jane Savill2, Sara Michienzi2, Henri Ménard7, Walter Maksymowych8 and Gilles Boire4, 1Division of Rheumatology, Université de Sherbrooke, Sherbrooke, QC, Canada, 2Augurex Life Sciences Corp., Vancouver, BC, Canada, 3Department of Medicine/Division of Rheumatology, Université de Sherbrooke, Sherbrooke, QC, Canada, 4Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada, 5Department of Medicine/Division of Rheumatology, Université de Sherbrooke, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada, 6Department of Medicine/Division of Rheumatology, University of Sherbrooke, Sherbrooke, QC, Canada, 7MSK Research Axis, McGill University Health Center Research Institute, Montreal, QC, Canada, 8Department of Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: The 14-3-3 family of conserved regulatory proteins consists of seven isoforms: α/β, γ, δ/ζ, ε, η, θ/τ and σ. These proteins exist as intracellular…
  • Abstract Number: 1100 • 2015 ACR/ARHP Annual Meeting

    Citrullinated Antigen-Specific B Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis: Identification and Phenotypic Characterization

    Priscilla Kerkman1, Ellen I.H. van der Voort1, Arnaud Zaldumbide2, Emeline Fabre1, Yoann Rombouts1, Theo Rispens3, Gertjan Wolbink4, Rob Hoeben2, Hergen Spits5, Dominique Baeten6, T. W. J. Huizinga1, René E. M. Toes1 and Hans Ulrich Scherer1, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, Netherlands, 3Sanquin Research, Amsterdam, Netherlands, 4Immunopathology, Sanquin Research, Amsterdam, Netherlands, 5Department of Cell Biology and Histology, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands, 6Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) is characterized by the presence of anti-citrullinated protein antibodies (ACPA) in the majority of patients. ACPA represent highly disease-specific biomarkers that…
  • Abstract Number: 1404 • 2014 ACR/ARHP Annual Meeting

    Presence and Significance of Anti-CCP Antibody in Patients with Interstitial Lung Disease with and without Clinically Apparent Rheumatoid Arthritis

    Muhammad Imran1, Shanley O'brien2, Mark Hamblin3 and Mehrdad Maz4, 1Rheumatology, University of Kansas Medical Center, Kansas City, KS, 2Internal Medicine, Kansas University Medical Center, Kansas city, MO, 3Pulmonary and Critical Care Medicine, ILD Clinic, Kansas University Medical Center, Kansas city, MO, 4Division of Rheumatology, University of Kansas Medical Center, Kansas City, KS

    Background/Purpose:   Interstitial lung disease (ILD) can be idiopathic or associated with underlying etiologies including rheumatoid arthritis (RA). The purpose of this study is to determine…
  • Abstract Number: 1377 • 2014 ACR/ARHP Annual Meeting

    Anti-Citrullinated Peptide Antibody Titers and the Prevalence of Interstitial Lung Disease in Patients with and without Rheumatoid Arthritis

    Chase Correia1, Melissa R. Bussey2, Brittany Panico1, Rong Guo3 and Rochella A. Ostrowski4, 1Internal Medicine, Loyola University Medical Center, Chicago, IL, 2Rheumatology, Division of Rheumatology, Loyola University Medical Center, Maywood, IL, 3Loyola University Medical Center, Chicago, IL, 4Rheumatology, Loyola University Medical Center, Maywood, IL

    Background/Purpose:   Rheumatoid arthritis (RA) is a multisystem inflammatory disease characterized by a symmetric, destructive polyarthritis.  Interstitial lung disease (ILD) is an extra-articular manifestation that…
  • Abstract Number: 1039 • 2014 ACR/ARHP Annual Meeting

    Interleukin-20 Is Triggered By TLR Ligands and Associates with Rheumatoid Arthritis Disease Activity

    Ladislav Senolt1, Klara Prajzlerova1, Hana Hulejova2, David Veigl3, Karel Pavelka1 and Jiri Vencovsky1, 1Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic, 2Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Prague, Czech Republic, 31st Orthopaedic Clinic, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovial inflammation and subsequent joint damage with systemic manifestations. Interleukin-20 (IL-20) has been…
  • Abstract Number: 388 • 2014 ACR/ARHP Annual Meeting

    Soluble TREM-1 Is a Biomarker of Anti-CCP-Positive, DMARD-Naive Early Rheumatoid Arthritis

    Shachaf Ofer-Shiber1, Elisheva Pokroy-Shapira2, Yair Molad3,4, Shirly Oren2, Hagit Shay-Aharoni2 and Ilan Babai5, 1Department of Internal Medicine H, Rabin Medical Center, Beilinson Hospital and Sackler Faculty of Medicine, Tel Aviv University, Petach Tikva, Israel, 2Rheumatology Unit, Rabin Medical Center, Beilinson Hospital and Sackler Faculty of Medicine, Tel Aviv University, Petach Tikva, Israel, 3Rheumatology Unit, Rabin Medical Center, Beilinson Hospital and Sackler Faculty of Medicine, Tel Aviv University, Petah Teqva, Israel, 4Laboratory of Inflammation Research, Felsenstein Medical Research Center, Sackler Faculty of Medicine, Tel Aviv University, Petach Tikva, Israel, 5Laboratory of Clinical Immunology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel

    Background/Purpose : Triggering receptor expressed on myeloid cells-1 (TREM-1) is a cell-surface receptor, expressed mainly on monocytes and neutrophils and involved in amplification of the inflammatory…
  • Abstract Number: 380 • 2014 ACR/ARHP Annual Meeting

    In Palindromic Rheumatism, Older Age, Shorter Interval Between Attacks and Positive Anti-CCP Antibodies May Predict Progression to RA

    Masatoshi Hayashi1,2, Jackie L. Nam3, Laura Hunt3, Elizabeth Hensor3, Toshihisa Kanamono4, Toshihisa Kojima5, Naoki Ishiguro5 and Paul Emery6, 1NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds., Leeds, United Kingdom, 25-22-1 Wakasato, Nagano Red Cross Hospital, Nagano, Japan, 3NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 4Departments of Orthopedic surgery and Rheumatology, Nagano Red Cross Hospital, Nagano, Japan, 5Orthopaedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Japan, 6NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds., United Kingdom, Leeds, United Kingdom

    Background/Purpose Palindromic rheumatism (PR) is a clinical syndrome characterised by episodes of joint swelling that settle spontaneously.  A proportion of patients with PR progress and…
  • Abstract Number: 371 • 2014 ACR/ARHP Annual Meeting

    The Impact of Missing Anti-Citrullinated Protein Antibody (ACPA) on Outcomes in Early Rheumatoid Arthritis: From the Canadian Early Arthritis Cohort

    Jenny Shu1, Vivian P. Bykerk2, Gilles Boire3, Carol A. Hitchon4, J. Carter Thorne5, Diane Tin6, Edward C. Keystone7, Boulos Haraoui8 and Janet E. Pope9, 1Medicine/Rheumatology, University of Western Ontario, London, ON, Canada, 2Rheumatology, Hospital for Special Surgery, New York, NY, 3Rheumatology Division, CHUS - Sherbrooke University, Sherbrooke, QC, Canada, 4Rheumatology, University of Manitoba, Winnipeg, MB, Canada, 5Southlake Regional Health Centre, Newmarket, ON, Canada, 6The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 7Medicine, University of Toronto, Toronto, ON, Canada, 8Rheumatology, Institut de rhumatologie de Montréal (IRM), Montréal, QC, Canada, 9St Joseph Health Care, London, ON, Canada

    Background/Purpose: The impact of missing ACPA in early inflammatory arthritis patients was studied to determine if failure to perform ACPA testing could cause a care…
  • Abstract Number: 124 • 2014 ACR/ARHP Annual Meeting

    Ultrasound Power Doppler Findings in the Wrists and Hands Joints of Anti-CCP Antibody Positive Individuals with Non-Specific Musculoskeletal Symptoms and the Development of Inflammatory Arthritis

    Jackie L. Nam, Laura Hunt, Elizabeth M.A. Hensor, Philip G. Conaghan, Richard J. Wakefield and Paul Emery, NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom

    Background/Purpose The use of musculoskeletal ultrasound is increasing in rheumatology practice. Recently we have shown that use of power Doppler signal (PD) on ultrasound in…
  • Abstract Number: 2921 • 2014 ACR/ARHP Annual Meeting

    Contraceptive Factors Are Associated with Serum Antibodies to Citrullinated Protein Antigens in Women at Elevated Risk for Future Rheumatoid Arthritis

    Sonia Khatter1, Mark C. Parish2, Marie L. Feser2, Jason R. Kolfenbach2, Ryan W. Gan3, Michael H. Weisman4, James R. O'Dell5, Ted R. Mikuls6, Richard M. Keating7, Peter K. Gregersen8, Jane H. Buckner9, V. Michael Holers10, Kevin D. Deane2, Jill M. Norris3 and M. Kristen Demoruelle2, 1University of Colorado School of Medicine, Aurora, CO, 2Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 3Epidemiology, Colorado School of Public Health, Aurora, CO, 4Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 5Veteran Affairs Nebraska Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, 6Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 7Division of Rheumatology, Scripps Clinic, La Jolla, CA, 8Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, 9Benaroya Research Institute at Virginia Mason, Seattle, WA, 10Rheumatology Division, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: The preclinical period of rheumatoid arthritis (RA) development is characterized by elevations of serum RA-related autoantibodies (Abs) including Abs to citrullinated protein antigens (ACPA)…
  • Abstract Number: 2660 • 2013 ACR/ARHP Annual Meeting

    Omega-3 Supplement Use Is Associated With a Reduced Risk Of Anti-Cyclic Citrullinated Protein Positivity In a Population Without Rheumatoid Arthritis, But At Risk For Future Disease

    Ryan W. Gan1, Kendra A. Young1, Gary O. Zerbe2, M. Kristen Demoruelle3, Michael H. Weisman4, Jane H. Buckner5, Peter K. Gregersen6, Ted R. Mikuls7, James R. O'Dell8, Richard M. Keating9, Michael J. Clare-Salzler10, Kevin D. Deane3, V. Michael Holers11 and Jill M. Norris1, 1Epidemiology, Colorado School of Public Health, Aurora, CO, 2Biostatistics and Informatics, Colorado School of Public Health / University of Colorado Anschutz Medical Campus, Aurora, CO, 3Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 4Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 5Benaroya Research Institute at Virginia Mason, Seattle, WA, 6Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, 7Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 8Dept of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 9Rheumatology Section, The University of Chicago, Chicago, IL, 10Experimental Pathology, University of Florida, College of Medicine, Gainesville, FL, 11Rheumatology Division, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: Rheumatoid arthritis (RA) is characterized by systemic inflammation and circulating autoantibodies, which can be present in serum years prior to RA diagnosis and can…
  • Abstract Number: 2412 • 2013 ACR/ARHP Annual Meeting

    Anti-CCP Antibodies and Increased Cartilage Turnover In Patients Developing Rheumatoid Arthritis

    Carl Turesson1, Christina Book2, Ulf Bergström2, Lennart Truedsson3, Lennart Jacobsson2 and Tore Saxne4, 1Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 2Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 3Department of Laboratory Medicine, Section of Microbiology, Immunology and Glycobiology, Lund University, Lund, Sweden, 4Section of Rheumatology, Deparment of Clinical Sciences, Lund, Lund University, Lund, Sweden

    Background/Purpose: Autoantibodies may be detected years before the onset of rheumatoid arthritis (RA). We have previously shown that levels of Cartilage oligomeric matrix protein (COMP),…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology